SEC-sourced researchBeta

GH

Guardant Health, Inc.

US markets

Data passport

CIK: 0001576280
Exchange: Nasdaq
Business activity: — · SIC 8071
Financial inputs: 6/6
Filing date: Oct 2, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 8:04 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

GH · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	563,948,000.0000	Feb 19, 2026
December 2024	739,016,000.0000	Feb 19, 2026
December 2025	982,021,000.0000	Feb 19, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	982,021,000.0000	-416,277,000.0000	-184,760,000.0000	2,013,659,000.0000	2,112,966,000.0000	Feb 19, 2026
December 2024	739,016,000.0000	-436,373,000.0000	-239,858,000.0000	1,485,609,000.0000	1,625,256,000.0000	Feb 19, 2026
December 2023	563,948,000.0000	-479,449,000.0000	-324,975,000.0000	—	—	Feb 19, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenues	$982.02M	December 2025	Feb 19, 2026	10-K
Previous period revenueRevenues	$739.02M	December 2024	Feb 19, 2026	10-K
Net incomeNetIncomeLoss	-$416.28M	December 2025	Feb 19, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$184.76M	December 2025	Feb 19, 2026	10-K
Total assetsAssets	$2.01B	December 2025	Feb 19, 2026	10-K
Total liabilitiesLiabilities	$2.11B	December 2025	Feb 19, 2026	10-K

New filings

Explore methodology ↗